is tirzepatide a glp-1 drug PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: A Major GLP-1 Drug Shortage

Big thanks to our clinical team for this breakthrough innovation

Made in the USA

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

This review article examines the translational evolution of glucagon-like peptide-1 receptor agonists (GLP-1RAs), tracing their progression from the discovery of exendin-4 in Gila monster venom to long-acting peptide analogues and the first orally delivered peptide therapy, oral semaglutide

GLP-1 access without insurance is achievable through compounded medications, patient assistance programs, and direct-to-patient models